FDA is investigating the ‘serious’ side effects of counterfeit semaglutide

Amid high demand and short supply of the weight-loss drug semaglutide, some patients have turned to counterfeit versions. Following several reports of patient harm associated with counterfeit semaglutide, FDA has opened an investigation into the cases and said that it is “vigilant in protecting the U.S. drug supply from these threats.”

The 5 biggest weight management drug questions (and our answers)

High demand leads to counterfeit semaglutide

Currently, the United States is facing a shortage of weight-loss drugs, including Novo Nordisk’s semaglutide, even as manufacturers make efforts to boost production.

In July, there were reports of some companies offering “generic” or...